Advanced Health Intelligence Ltd operates in the global digital health sector. It provides assessment tools to healthcare providers, caregivers, insurers, and governments globally, leveraging smartphones for convenience. The company’s mission is focused on healthcare outcomes improvement, health literacy enhancement, and early detection and management of various health conditions.
Founded in 2014, AHI has been involved in Health-tech innovation, starting with the introduction of on-device body dimensioning capability. Its patented technology has evolved into various solutions in the digitised healthcare domain. Key offerings from AHI include body dimension and composition assessments for identifying obesity-related comorbidities like diabetes, blood biomarker prediction (including HbA1C, HDL, LDL, and 10-year mortality risk), transdermal optical imaging for vital signs and cardiovascular disease risk estimates, on-device dermatological skin identification capable of recognising various skin conditions, and assistance to partners in delivering personalised health coaching.
